Seroprotection for Diphtheria, Pertussis, Tetanus and Measles in Children With Nephrotic Syndrome

Indian Pediatr. 2021 Mar 15;58(3):233-236.

Abstract

Objective: To determine seroprotective titres for diphtheria, pertussis, tetanus and measles in children with nephrotic syndrome who had received essential immunization.

Methods: Children (2-18 years) with steroid sensitive nephrotic syndrome (SSNS) or steroid-resistant nephrotic syndrome (SRNS) who were in disease remission and had received essential childhood immunization were included. Anti-diphtheria, anti-pertussis, anti-tetanus and anti-measles antibody titres were measured.

Results: Seventy-six (40 with SSNS; 36 with SRNS) children with mean (SD) age 7.54 (3.96) years were enrolled. The time elapsed since last vaccination was >5 years in 68.4% patients. The seroprotection rates for diphtheria, tetanus, pertussis, and measles were 86.8%, 93.4%, 31.6% and 77.6% respectively; lower in SRNS subjects compared to SSNS. Robust seroprotection titers (1.0 IU/mL) for diphtheria were seen in 23.8% SSNS and 17.9% SRNS; P=0.04, and for tetanus in 69.3% SSNS and 43.8% of SRNS subjects; P=0.03, respectively.

Conclusions: Children with nephrotic syndrome especially those with SRNS have lower seroprotective titers for diphtheria, tetanus, pertussis and measles, necessitating a booster dose of DPT/DT/Td and MR/MMR.

MeSH terms

  • Antibodies, Bacterial
  • Child
  • Diphtheria* / epidemiology
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Humans
  • Immunization, Secondary
  • Measles*
  • Nephrotic Syndrome* / complications
  • Tetanus*
  • Whooping Cough*

Substances

  • Antibodies, Bacterial
  • Diphtheria-Tetanus-Pertussis Vaccine